What Grupo Centroflora does

Grupo Centroflora is a privately held Brazilian pharmaceutical company founded in 1957 that manufactures botanical extracts, essential oils, and isolated active pharmaceutical ingredients (APIs) primarily from Brazilian biodiversity. The company operates two GMP-certified facilities — a herbal extracts and essential oils unit in Botucatu (Centroflora Phyto, with Industry 4.0 automation, operational since 2021) and an IFA manufacturing facility in Parnaíba — and runs an R&D and pilot plant at Centroflora Inova in Campinas (inaugurated 2019). Subsidiary CentroAgro handles agricultural production, while Phytobios (wholly owned since 2012) focuses on biodiversity-derived innovation, and L4P (2016) handles pharmaceutical logistics. The group also runs a non-profit, Instituto Floravida, and a community-based supplier program (Parcerias para um Mundo Melhor) covering 4,000+ farming families with full traceability.

The company's revenue model combines sale of botanical extracts and APIs (Camu Camu, Açaí, Guaraná, Silymarin, Jaborandi/Pilocarpine, and others across dozens of plant species) with fee-based contract development and manufacturing (CDMO) services covering APIs, food and cosmetic ingredients, technology transfer, and scale-up. Two anchor joint ventures are commercially central: CMS Centroflora with Boehringer Ingelheim (2014) for API production, and Brazbio with Givaudan (2017) for global sustainable ingredient distribution. Ancillary service revenue streams include regulatory and scientific consulting (DMF, CEP, EDMF, ASMF dossiers), analytical method development and validation, and agronomic services. Multi-chemistry analytical methods (UV, HPLC/UPLC, GC) comply with ANVISA, FDA, and ICH guidelines.

Go-to-market is enterprise field sales targeting global pharmaceutical, nutraceutical, cosmeceutical, and compounding pharmacy customers, supplemented by active participation in eight major international trade shows annually (CPHI Frankfurt, SupplySide West, Vitafoods, Foodex Tokyo, Gulfood Dubai, FISA, FCE, NIS) and a customer portal for existing accounts. Innovation differentiation rests on the Molecular Power House (MPH) platform developed with CNPEM using the Sirius synchrotron for novel compound discovery, the Plant Fraction Library, the Inovafito Brasil ecosystem platform (with Fiocruz, Instituto Stela, and Biominas since 2022), and AI-augmented process development using QbD and DoE methodologies. Certifications include GMP, FSSC 22000, Kosher, and Halal, supporting pharmaceutical and food-grade market entry globally.

Name

Grupo Centroflora

Legal name

Grupo Centroflora

Website

https://centroflora.com.br

Company type

Private

Founded year

1957

Operating status

Operating

Headcount range

101–250 employees

Short description

Grupo Centroflora is a privately held Brazilian pharmaceutical manufacturer founded in 1957 that produces botanical extracts, essential oils, and isolated active pharmaceutical ingredients (APIs) derived from Brazilian biodiversity for global pharmaceutical, nutraceutical, and cosmeceutical customers, with two GMP-certified facilities and 67 years of industry expertise.

Ownership category

akta.pro rank

Product category

Botanical API Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)

akta.pro secondary industry

Herbal & Botanical Supplements (CRADAGAD)

Keywords

• Botanical extract manufacturing
• Pharmaceutical API manufacturing
• CDMO contract services
• Natural ingredient supply
• Herbal medicine ingredients

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing / CDMO Services: Comprehensive contract manufacturing and development services for Active Pharmaceutical Ingredients (APIs), food ingredients, cosmetic ingredients, essential oils, and botanical extracts. Includes technology transfer, scale-up from bench to industrial, and GMP-certified production.
2. Botanical Extract Products: Sale of botanical extracts, essential oils, and isolated active pharmaceutical ingredients from dozens of plant species including Camu Camu, Acai, Guarana, Jaborandi, Silymarin, and others.
3. Regulatory and Scientific Consulting: Regulatory consulting services for pharmaceutical technology transfer, international registration documents (CTD format, DMF, CEP, EDMF, ASMF), GRAS safety dossiers, and ANVISA regulation of herbal medicines.
4. Agronomic Services: Agronomic services including botanical supply chain development, GAP implementation, supplier prospection, and agricultural experimental studies for raw material sourcing.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Grupo Centroflora manufactures and supplies botanical extracts, essential oils, and active pharmaceutical ingredients (APIs) derived from Brazilian biodiversity, including products such as Camu Camu, Jabuticaba, Acerola, Maracujá, Açaí, Guaraná, Silymarin, and Pilocarpine. The company also provides CDMO/outsourcing manufacturing, R&D innovation, regulatory and scientific consulting, analytical methodology development, and agronomic services across two GMP-certified facilities.

Product overview

Grupo Centroflora is a Brazilian pharmaceutical/botanical company offering a comprehensive ecosystem of botanical extracts, active pharmaceutical ingredients (APIs), and related services. The product portfolio includes dozens of plant species processed into extracts, essential oils, and isolated APIs (products like Camu Camu, Jabuticaba, Acerola, Maracujá, Açaí, Guaraná, Silymarin). The service ecosystem includes CDMO/outsourcing manufacturing, extract development innovation (Centroflora Inova unit), regulatory and scientific consulting, R&D for new products, dossier/DMF preparation support, analytical methodology development, and agronomic services. Key units include Centroflora Inova (R&D), Phytobios (innovation subsidiary), Centroflora Phyto (herbal API manufacturing), CentroAgro (agricultural operations), and Brazbio (sustainable ingredients joint venture with Givaudan).

Differentiator

Problem solved

Functional benefit

Brands

• Centroflora Inova: State-of-the-art R&D and innovation unit located in Campinas (SP), focused on developing proprietary botanical extracts and transforming Brazilian biodiversity into health solutions. Offers technology to transform plant-based active pharmaceutical ingredients into market products.
• Centroflora Phyto
• Centroflora IFA
• CentroAgro
• Brazbio
• Phytobios
• L4P
• CMS Centroflora
• Instituto Floravida
• Inovafito Brasil

Products and services

• Camu Camu Extract Extract from Myrciaria dubia, processed into various extract types following rigorous national and international manufacturing standards for pharmaceutical and nutraceutical buyers.
• Jabuticaba Extract Extract from Myrciaria cauliflora with anti-inflammatory and antioxidant properties, sold to pharmaceutical and nutraceutical buyers.
• Acerola Extract Extract from Malpighia emarginata, processed following rigorous manufacturing standards for nutraceutical and food ingredient customers.
• Maracujá (Passion Fruit) Extract Extract from Passiflora edulis L. with antioxidant and calming agent properties, sold to pharmaceutical and nutraceutical buyers.
• Açaí Extract Extract from Euterpe oleracea, processed following rigorous manufacturing standards for nutraceutical and pharmaceutical customers.
• Guaraná Extract Extract from Paullinia cupana, available in liquid and powder forms for nutraceutical and food ingredient buyers.
• Silymarin Extract Extract from Sylibum marianum with hepatoprotective properties, sold as a botanical active to pharmaceutical companies.
• Jaborandi (Pilocarpine API) Active pharmaceutical ingredient derived from Pilocarpus microphyllus, used in medications for glaucoma and xerostomia, with strategic expansion project via Senai Embrapii partnership.
• Outsourcing / CDMO Services Comprehensive contract manufacturing and development services including manufacturing of APIs, food ingredients, cosmetic ingredients, drying of food ingredients (SIF/MAPA), essential oil extraction, and planting/cultivation/drying of plant species for pharmaceutical and nutraceutical buyers.
• Innovation in Extract Development R&D service combining traditional knowledge with cutting-edge technology for sustainable health solutions, including scientific research on potential extracts, radical and incremental innovation, and bench-to-pilot scale development for pharmaceutical clients.
• Regulatory and Scientific Consulting Technical and regulatory support including pharmaceutical technology transfer consulting, preparation of regulatory documents for international registrations, safety documents, and regulatory consulting for herbal medicines and specific pharmaceuticals.
• Research and Development of New Products R&D service utilizing scientific tools such as Quality by Design (QbD), Design of Experiments, and AI-driven studies, delivered by a team of masters and PhDs in Natural Products to accelerate product time-to-market.
• Technical-Regulatory Support for Dossiers and DMFs Assistance in preparation of dossiers and Drug Master Files in CTD format (DMF, CEP, EDMF, ASMF, Technical Package) for international registrations, GRAS safety dossiers, and regulatory consulting for herbal medicines.
• Development and Validation of Analytical Methodologies Expert service in chromatographic methods (UV, HPLC/UPLC, GC) using high-tech equipment, following ANVISA, FDA, and ICH guidelines, including protocol and validation report preparation for pharmaceutical clients.
• Agronomic Services Integrated services ensuring quality, traceability, and sustainability of botanical raw materials, including botanical supply chain development, cultivation practices, GAP implementation, agricultural technical visits, and experimental studies.

Quantifiable outcome

• Two GMP-certified facilities meeting highest global standards
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered supporting, core and flagship.

• NintxsupportingTechnology or Integration · 1 January 2023Startup partnership at Centroflora Inova facility in Campinas for innovation and technology development in botanical extracts.
• FiocruzcoreStrategic or Co-development Partner · 1 January 2022Collaboration on Inovafito Brasil platform for enabling production of herbal medicines by connecting industry, academia, and government, leveraging regulatory requirements and Technology Readiness Levels.
• Instituto StelasupportingStrategic or Co-development Partner · 1 January 2022Partner in Inovafito Brasil platform for enabling production of herbal medicines through industry-academia-government collaboration.
• BiominassupportingStrategic or Co-development Partner · 1 January 2022Partner in Inovafito Brasil platform for enabling production of herbal medicines through industry-academia-government collaboration.
• GivaudancoreStrategic or Co-development Partner · 1 January 2017Joint venture Brazbio with Givaudan for managing the Parcerias para um Mundo Melhor sustainable sourcing program. Ensures traceability and quality of natural ingredients supplied, as well as sustainability of crops in portfolio.
• Boehringer IngelheimcoreStrategic or Co-development Partner · 1 January 2014API project partnership through CMS Centroflora Joint Venture for pharmaceutical active ingredient development and manufacturing.
• PhytobioscoreOthers · 1 January 2012Fully incorporated subsidiary (2012) specializing in sustainable research, development, and innovation derived from biodiversity. Focused on high-value technological innovations with global impact, adhering to genetic heritage legislation.
• UNESP (Universidade Estadual Paulista)supportingStrategic or Co-development Partner · 1 January 2002Partnership with Centrofauna program for rehabilitation, release, and monitoring of wild animals rescued from trafficking and mistreatment.
• CNPEM (Centro Nacional de Pesquisa em Energia e Materiais)flagshipStrategic or Co-development PartnerPartnership for Molecular Power House (MPH) project - innovative approach to discover new bioactive natural products from Brazilian biodiversity using synchrotron light sources and computational platforms. Also collaborated on plant fraction library using Sirius synchrotron technology.
• Senai Embrapii Unit for Green Chemistry TechnologiescoreStrategic or Co-development PartnerPartnership on strategic jaborandi production expansion project to increase pilocarpine content for glaucoma and xerostomia medications. Project received approximately R$ 2.5 million in investments.

Scale indicators6 records

Recent moves13 records

Expansion highlights6 records

Broad incumbents

• Givaudan (Active Beauty & Natural Ingredients): Swiss global flavor and fragrance major that, through Active Beauty and its Taste & Wellbeing unit, supplies botanical and natural ingredients to pharma/nutraceutical customers — overlapping with Centroflora's portfolio and serving as both JV partner (Brazbio) and competitor.
• IFF (Health & Biosciences): Global major serving pharma, food and beverage with natural/botanical ingredients via its Health & Biosciences division. Much larger scale but overlapping product categories and customer segments.
• ADM (Wild Flavors & Specialty Ingredients): Global agricultural major with significant botanical/natural-ingredient operations serving nutrition and pharma. Competes with Centroflora on standardized plant-derived ingredients and APIs at scale.
• Kemin Industries: US-headquartered ingredient manufacturer serving human/animal nutrition and health markets with botanical and natural ingredients. Broader portfolio and global scale, but overlapping botanical ingredient activities and customer base.

Direct peers

• Indena SpA: Italian manufacturer of botanical extracts and active ingredients for the pharmaceutical and nutraceutical industries. Directly comparable as a GMP-certified producer of standardized plant-derived APIs serving the same customer set.
• Nexira: French supplier of plant-based ingredients (botanical extracts, nutraceutical actives) for nutrition and pharma. Comparable product portfolio and CDMO-style service orientation.
• Martin Bauer Group: German global supplier of botanical extracts and teas for food, beverage, and pharma uses. Closely matches Centroflora's vertically-integrated model from sustainable cultivation through standardized extract manufacturing.
• Sabinsa Corporation: US/India ingredient manufacturer specializing in standardized herbal extracts and APIs (e.g., curcuminoids, boswellia). Overlaps heavily on botanical API catalog and pharma/nutraceutical channels.
• Euromed Group: Spanish producer of standardized botanical extracts for pharma and nutraceuticals. Closely comparable in product technology (chromatographic purification, extracts, APIs) and target customers.

Emerging players

• Botanic Healthcare: India-based supplier of standardized herbal extracts, APIs and nutraceutical ingredients. Comparable product model with comparable customer types but smaller scale and primarily Asia-centric reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/GrupoCentroflora
• LinkedInlinkedin.com/company/grupocentroflora
• Instagraminstagram.com/grupocentroflora
• Facebookfacebook.com/grupocentroflora

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Centroflora